In vivo switching of human melanoma cells between proliferative and invasive states.
暂无分享,去创建一个
R. Dummer | K. Hoek | Natalie C. Schlegel | O. Eichhoff | S. Hemmi | U. Döbbeling | N. Kobert | L. Schaerer | N. Schlegel | Leo Schaerer
[1] Química. Microphthalmia-Associated Transcription Factor , 2010 .
[2] G. Salti,et al. Role of microphthalmia transcription factor (Mitf) in melanoma differentiation. , 2007, Biochemical and biophysical research communications.
[3] A. Sasse,et al. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. , 2007, The Cochrane database of systematic reviews.
[4] Jane Goodall,et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. , 2006, Genes & development.
[5] D. Ribatti,et al. Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination , 2006, Clinical and Experimental Medicine.
[6] D. Schadendorf,et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.
[7] M. Hendrix,et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness , 2006, Nature Medicine.
[8] M. Hendrix,et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Meltzer,et al. The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment , 2006, Journal of cellular and molecular medicine.
[10] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[11] A. Jacobs,et al. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] R. Marais,et al. Elevated expression of MITF counteracts B-RAF–stimulated melanocyte and melanoma cell proliferation , 2005, The Journal of cell biology.
[13] S. Byers,et al. The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer , 2005, Oncogene.
[14] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[15] M. Khaled,et al. Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells , 2005, The Journal of cell biology.
[16] B. Ljung,et al. The gene expression signatures of melanoma progression , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Larue,et al. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression , 2005, Nature.
[18] R. Delston,et al. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A , 2005, The Journal of cell biology.
[19] T. Golub,et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. , 2004, Cancer cell.
[20] N. Copeland,et al. Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.
[21] R. Krumlauf,et al. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex , 2004, Development.
[22] Naoto Ueno,et al. The TAK1-NLK Mitogen-Activated Protein Kinase Cascade Functions in the Wnt-5a/Ca2+ Pathway To Antagonize Wnt/β-Catenin Signaling , 2003, Molecular and Cellular Biology.
[23] M. Okabe,et al. Small interfering RNA and gene silencing in transgenic mice and rats , 2002, FEBS letters.
[24] Stephen L. Lessnick,et al. β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor , 2002, The Journal of Cell Biology.
[25] D. Fisher,et al. Identification of Aim-1 as the underwhiteMouse Mutant and Its Transcriptional Regulation by MITF* , 2002, The Journal of Biological Chemistry.
[26] A. Zorn,et al. Wnt signalling: Antagonistic Dickkopfs , 2001, Current Biology.
[27] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[28] Harris,et al. Morphological and immunophenotypic variations in malignant melanoma , 2000, Histopathology.
[29] R. Dummer,et al. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. , 1998, Human gene therapy.
[30] R. Dummer,et al. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. , 1998, The Journal of investigative dermatology.
[31] A. Bassols,et al. The effect of TGF-beta 1 on cell proliferation and proteoglycan production in human melanoma cells depends on the degree of cell differentiation. , 1996, Cancer letters.
[32] C. Garbe,et al. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. , 1994, Anticancer research.
[33] J. Gerdes,et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins , 1993, The Journal of cell biology.
[34] S. Bruno,et al. Cell cycle dependent expression and stability of the nuclear protein detected by Ki‐67 antibody in HL‐60 cells , 1992, Cell proliferation.
[35] A. Levene. On the histological diagnosis and prognosis of malignant melanoma. , 1980, Journal of clinical pathology.
[36] A. Breslow. Tumor thickness in evaluating prognosis of cutaneous melanoma. , 1978, Annals of surgery.
[37] H. Dardik. Umbilical vein grafts. , 1978, Annals of surgery.
[38] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.
[39] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[40] S. Påhlman,et al. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. , 2006, Advances in experimental medicine and biology.
[41] L. Coussens,et al. Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.
[42] R. Buscà,et al. [Hypoxia inducible factor 1a is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells]. , 2006, Medecine sciences : M/S.
[43] S. Byers,et al. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. , 2005, Oncogene.
[44] H. Müller-Hermelink,et al. Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[45] M. Sporn,et al. Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.